- Home
- ELV vs XNCR Comparison
ELV vs XNCR Comparison
Compare ELV & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELV
- XNCR
- Stock Information
- Founded
- ELV 1944
- XNCR 1997
- Country
- ELV United States
- XNCR United States
- Employees
- ELV N/A
- XNCR N/A
- Industry
- ELV Medical Specialities
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- ELV Health Care
- XNCR Health Care
- Exchange
- ELV Nasdaq
- XNCR Nasdaq
- Market Cap
- ELV 61.8B
- XNCR 547.8M
- IPO Year
- ELV N/A
- XNCR 2013
- Fundamental
- Price
- ELV $313.32
- XNCR $9.87
- Analyst Decision
- ELV Buy
- XNCR Buy
- Analyst Count
- ELV 14
- XNCR 10
- Target Price
- ELV $399.00
- XNCR $20.22
- AVG Volume (30 Days)
- ELV 2.0M
- XNCR 762.5K
- Earning Date
- ELV 10-16-2025
- XNCR 11-05-2025
- Dividend Yield
- ELV 2.22%
- XNCR N/A
- EPS Growth
- ELV N/A
- XNCR N/A
- EPS
- ELV 23.39
- XNCR N/A
- Revenue
- ELV $189,254,000,000.00
- XNCR $146,929,000.00
- Revenue This Year
- ELV $12.49
- XNCR $23.31
- Revenue Next Year
- ELV $5.45
- XNCR N/A
- P/E Ratio
- ELV $13.17
- XNCR N/A
- Revenue Growth
- ELV 10.21
- XNCR N/A
- 52 Week Low
- ELV $273.71
- XNCR $6.92
- 52 Week High
- ELV $554.03
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- ELV 52.25
- XNCR 73.19
- Support Level
- ELV $304.33
- XNCR $8.49
- Resistance Level
- ELV $319.24
- XNCR $8.73
- Average True Range (ATR)
- ELV 8.27
- XNCR 0.46
- MACD
- ELV -0.21
- XNCR 0.15
- Stochastic Oscillator
- ELV 42.30
- XNCR 86.75
About ELV Elevance Health Inc.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of June 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.